Advanced search×

Variagenics, inc.

Ann E Ferentz and Joseph S Mohr

Pharmacogenomics 3(5):713-7 (2002) PMID 12223056

Variagenics, Inc. develops molecular diagnostic tests by identifying genetic markers associated with response to cancer therapies, with the goal of optimizing patient care. Toward this end, the company analyzes genetic variations in both normal and tumor cells, including SNPs, haplotypes, loss of heterozygosity, and gene expression levels. The company's approach of analyzing multiple types of genetic variations increases the likelihood of finding significant associations with drug response and successfully developing diagnostics. Variagenics is pursuing marker identification and diagnostic development through both biopharmaceutical collaborations and internal research programs.

DOI: 10.1517/14622416.3.5.713
Version: za2963e q8za1 q8zb1 q8zcf q8zd2 q8ze6 q8zfe q8zgc

Similar articles you may find interesting…

  1. The influence of insects on decomposition rate in buried and surface remains.
    Tal Simmons, Peter A Cross, ... Colin Moffatt

    J Forensic Sci 55(4):889-92 (2010) PMID 20412365

    This article reports results of a comparative study of decomposition rates of wild rabbit (Oryctolagus cuniculus) which were either (i) buried after exposure to insect activity, (ii) buried without exposure, (iii) kept above ground behind an insect screen, or (iv) continuously expose...
  2. The use of adhesive tape for recovery of DNA from crime scene items.
    Mark Barash, Ayeleth Reshef, and Paul Brauner

    J Forensic Sci 55(4):1058-64 (2010) PMID 20456579

    We report on one tape that met both these criteria. Three different cases are presented which demonstrate the usefulness of adhesive tape sampling of crime items. Finally, the advantages of the tape collection technique are discussed and guidelines for preferred areas of tape sampling on various cas...